Now, Zydus Cadila gets DCGI nod for human trials of Covid vaccine

After Bharat Biotech, now Ahmedabad-based drug major Cadila Healthcare Ltd (Zydus Cadila) has bagged the Drug Controller General of India (DCGI)'s - Central Drugs Standard Control Organisation (CDSCO) nod for initiating phase-I/II human clinical trials for its Covid-19 vaccine.

Zydus Cadila has already successfully completed preclinical phase for its plasmid DNA vaccine candidate ZyCoV-D developed indigenously at its Vaccine Technology Centre in Ahmedabad. According to the company, Zydus has already manufactured clinical GMP batches of ZyCoV-D for human clinical trials and plans to initiate the same this month across multiple sites in the country on over 1000 subjects.

With the